title: No acute change of serum erythropoietin in response to hypocalcemia or antihypertensive agents in uremic patients.
abstract: Endogenous erythropoietin (EPO) secretion can still be modulated in patients with end-stage renal failure but only in response to strong stimuli. Thus even anephric dialysis patients are able to increase EPO production acutely when exposed to a marked hypoxic stimulus. The present study was designed to test the hypothesis that a decrease of plasma calcium or the administration of various antihypertensive agents might be able to induce acute changes of plasma EPO concentration. Four groups of chronic hemodialysis patients were studied. Eight patients volunteered for the induction of an acute, transient hypocalcemia via a calcium-free dialysate during the initial 60 min of a regular dialysis session of 240 min. Plasma immunoreactive (i) EPO, total calcium, and intact parathyroid hormone (iPTH1-84), as well as blood ionized calcium and blood gases were measured before as well as 30, 60, 120 and 240 min after the start of dialysis. In addition, plasma iEPO was measured 48 h after the session. Patients of group 2 (n = 6), group 3 (n = 6), and group 4 (n = 7) received the day after a hemodialysis session a single dose of either acetazolamide, furosemide, or enalapril, respectively, and their plasma iEPO was determined before and 3, 6 and/or 24 h after drug administration. In group 1, plasma total calcium decreased from 2.39 +/- 0.07 mM (mean +/- SEM) to 1.98 +/- 0.02 and 1.83 +/- 0.03 mM after 30 and 60 min of dialysis, respectively, and blood ionized calcium from 1.28 +/- 0.04 to 1.02 +/- 0.03 and 0.92 +/- 0.04 mM, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Département de Néphrologie, INSERM, Hôpital Necker-Enfants Malades, Paris, France.
authors.forename: P
authors.initials: P
authors.lastname: Ureña
authors.forename: L
authors.initials: L
authors.lastname: Bererhi
authors.forename: S
authors.initials: S
authors.lastname: Houhou
authors.forename: F
authors.initials: F
authors.lastname: Bournerias
authors.forename: K U
authors.initials: KU
authors.lastname: Eckardt
authors.forename: A
authors.initials: A
authors.lastname: Kurtz
authors.forename: T B
authors.initials: TB
authors.lastname: Drüeke
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000494:pharmacology*; D002118:Calcium / Q000097:blood*; D002908:Chronic Disease; D015314:Dialysis Solutions; D004921:Erythropoietin / Q000097:blood*; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000188:drug therapy
chemical_list: D000959:Antihypertensive Agents; D015314:Dialysis Solutions; D010281:Parathyroid Hormone; D004921:Erythropoietin; D002118:Calcium